Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 for Radiation Dermatitis in Breast Cancer
NCT05190770Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Birch bark extract in radiation dermatitis, sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2021; status: completed.
02
Drugs
Birch bark extract
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT05190770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05190770.